Loading company
Loading
Latest annual · FY2018
Millions- Free cash flow
- (52)
Latest quarter · Q4 FY2018
Millions- Total revenues
- 0
- Gross profit
- (1)
- Operating income
- (14)
- Net income
- (14)
- Free cash flow
- (12)
IMMUNE DESIGN CORP. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.2 million | $7.2 million | -69.5% | 10-K 2019-03-13 · proof |
| Gross profit | $761,000 | $7.1 million | -89.3% | 10-K 2019-03-13 · proof |
| Operating income | -$57.1 million | -$52.8 million | 10-K 2019-03-13 · proof | |
| Net income | -$54.8 million | -$51.9 million | 10-K 2019-03-13 · proof | |
| Cash from operating activities | -$51.7 million | -$46.9 million | 10-K 2019-03-13 · proof | |
| Free cash flow | -$52.1 million | -$47.3 million | 10-K 2019-03-13 · proof | |
| Total assets | $101 million | $153.8 million | -34.4% | 10-K 2019-03-13 · proof |
| Total liabilities | $9 million | $14.6 million | -38.8% | 10-K 2019-03-13 · proof |
| Cash and cash equivalents | $77.9 million | $72.5 million | +7.6% | 10-K 2019-03-13 · proof |
- What was IMMUNE DESIGN CORP.'s revenue in fiscal 2018?
- IMMUNE DESIGN CORP. reported revenue of $2.2 million for fiscal 2018 (the year ended Dec 31, 2018), against $7.2 million the year before (-69.5%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was IMMUNE DESIGN CORP.'s gross profit in fiscal 2018?
- IMMUNE DESIGN CORP. reported gross profit of $761,000 for fiscal 2018 (the year ended Dec 31, 2018), against $7.1 million the year before (-89.3%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was IMMUNE DESIGN CORP.'s operating income in fiscal 2018?
- IMMUNE DESIGN CORP. reported operating income of -$57.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$52.8 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was IMMUNE DESIGN CORP.'s net income in fiscal 2018?
- IMMUNE DESIGN CORP. reported net income of -$54.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$51.9 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was IMMUNE DESIGN CORP.'s cash from operating activities in fiscal 2018?
- IMMUNE DESIGN CORP. reported cash from operating activities of -$51.7 million for fiscal 2018 (the year ended Dec 31, 2018), against -$46.9 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was IMMUNE DESIGN CORP.'s free cash flow in fiscal 2018?
- IMMUNE DESIGN CORP. reported free cash flow of -$52.1 million for fiscal 2018 (the year ended Dec 31, 2018), against -$47.3 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are IMMUNE DESIGN CORP.'s total assets?
- As of Dec 31, 2018, IMMUNE DESIGN CORP. reported total assets of $101 million, against $153.8 million a year earlier (-34.4%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are IMMUNE DESIGN CORP.'s total liabilities?
- As of Dec 31, 2018, IMMUNE DESIGN CORP. reported total liabilities of $9 million, against $14.6 million a year earlier (-38.8%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are IMMUNE DESIGN CORP.'s cash and cash equivalents?
- As of Dec 31, 2018, IMMUNE DESIGN CORP. reported cash and cash equivalents of $77.9 million, against $72.5 million a year earlier (+7.6%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1437786&period_type=annual&limit=5"Information only, not investment advice.